Rare disease diagnosis remains a key challenge

Maintaining the voice of rare diseases in a new, virtual world: Insights from the European Conference on Rare Diseases (ECRD) 2020

Rare disease diagnosis remains a key challenge

Can we drive a change in perceptions and attitudes by reframing rare diseases and stressing the importance of patient groups?

Alpharmaxim work closely with industry to raise awareness of rare diseases, developing educational materials and resources for healthcare professionals and helping to bring rare diseases into the spotlight.

There is an important need for physicians to understand the relevance of rare diseases within their clinical career and to consider rare diseases when the clinical picture doesn’t provide all the answers
Further education around genetics and rare diseases for medical students is needed
Very few general practitioners have access to rare disease-specific internet resources such as Orphanet; there is limited information regarding when to consider a rare disease and what to do when you come across one in clinical practice

Be prepared to truly demonstrate your commitment to the rare disease field, particularly in these uncertain times.

Talk to us about how we can transform your communications

Why Plain Language Summaries are vital in rare disease communications

Plain language summaries can translate complex science for different audiences. But what are they, and how do they improve awareness?

What can COVID-19 campaigns tell us about increasing vaccine uptake?

We examine what lessons we can take from the COVID-19 vaccine campaigns, and how behavioural science insights may help to drive vaccine uptake.

Transforming the rare disease landscape

Over the coming months, we’ll be looking at how new, tailored approaches to communications could help transform the rare disease landscape.